...
首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy.
【24h】

Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy.

机译:在先前通过化学疗法治疗的局部缺血预处理人类肝脏中同时诱导坏死,凋亡和自噬。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Liver pathology induced by chemotherapy (steatosis or vascular injury) is known to increase the liver's sensitivity to ischemia/ reperfusion (I/R) injury, thereby increasing morbidity and mortality after liver resection. Our aim was to assess whether ischemic preconditioning (IP) reduces I/R injury to livers with chemotherapy-induced pathology. METHODS: We analyzed a series of livers from patients treated with chemotherapy for colorectal cancer who underwent IP (n=30) or not (n=31) before hepatectomy. All but one of the livers exhibited chemotherapy-induced steatosis and/ or peliosis before the I/R insult. RESULTS: Necrosis was less frequent (p=0.038) in livers with IP than in the others. IP had no influence on apoptosis as assessed by terminal transferase uridyl nick-end labeling (TUNEL) assay or caspase-3, -8 and -9 expression. IP induced a twofold increase in B-cell leukemia/ lymphoma 2 (Bcl-2; p<0.05), which was localized to hepatocytes of centrolobular and peliotic areas and colocalized with the autophagy protein beclin-1 in livers with IP, suggesting their coordinated role in autophagy. Increased expression of the phosphorylated Bcl-2 was observed in preconditioned livers and was associated with a decreased immunoprecipitation of beclin-1 and the increased expression of light chain 3 type II (LC3-II). The increased number of autophagic vacuoles seen by electron microscopy confirmed an association of autophagy in chemotherapy-injured livers following IP. However, the differences in protein expression were not reflected in postresection liver-injury tests or measure of patient morbidity. CONCLUSIONS: IP is associated with a reduction in necrosis of hepatocytes already damaged by chemotherapy and an activation of autophagy. Bcl-2 and beclin-1 could be major targets in the regulation of cell death during I/R injury.
机译:背景/目的:已知由化学疗法(脂肪变性或血管损伤)引起的肝病理会增加肝脏对缺血/再灌注(I / R)损伤的敏感性,从而增加肝切除后的发病率和死亡率。我们的目的是评估缺血预处理(IP)是否能降低化疗诱发的病理学对肝脏的I / R损伤。方法:我们分析了接受肝癌切除术前接受IP(n = 30)或未接受IP(n = 31)的大肠癌化疗患者的一系列肝脏。在I / R损伤之前,除一只肝脏外,所有肝脏均表现出化疗诱导的脂肪变性和/或骨质疏松。结果:与其他肝相比,IP肝坏死的发生率较低(p = 0.038)。通过末端转移酶尿嘧啶缺口末端标记(TUNEL)分析或caspase-3,-8和-9表达评估IP对细胞凋亡没有影响。 IP诱导肝细胞B细胞白血病/淋巴瘤2的增加两倍(Bcl-2; p <0.05),其在IP肝中定位于中心小叶和腹水区域的肝细胞中,并与自噬蛋白beclin-1共定位,提示它们是协同的在自噬中的作用。在预处理的肝脏中观察到磷酸化的Bcl-2表达增加,并且与beclin-1的免疫沉淀减少和II型轻链3(LC3-II)表达增加有关。电镜观察到的自噬空泡数量的增加证实了IP后化疗损伤的肝脏中自噬的相关性。但是,蛋白质表达的差异未在切除后的肝损伤试验或患者发病率的测量中反映出来。结论:IP与已经被化疗破坏的肝细胞坏死的减少和自噬的激活有关。 Bcl-2和beclin-1可能是I / R损伤过程中细胞死亡调控的主要靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号